Yuyu Pharma (000220) — Net Asset Quality Index
Yuyu Pharma (000220) has a Net Asset Quality Index of 68.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩202.42 Billion minus total liabilities of ₩63.32 Billion yields net assets of ₩139.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Yuyu Pharma debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Yuyu Pharma Net Asset Quality Index Over Time (2011–2024)
This chart shows how Yuyu Pharma's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 68.7%, representing net assets of ₩139.10 Billion against total assets of ₩202.42 Billion KRW. For live market cap and overall valuation, see 000220 market cap.
Annual Net Asset Quality Index for Yuyu Pharma (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Yuyu Pharma from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Yuyu Pharma to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.0% | ₩135.06 Billion | ₩207.69 Billion | ₩72.62 Billion | ▲ +4.3 pp |
| 2023 | 60.7% | ₩120.36 Billion | ₩198.21 Billion | ₩77.86 Billion | ▼ -2.5 pp |
| 2022 | 63.2% | ₩123.37 Billion | ₩195.21 Billion | ₩71.83 Billion | ▼ -3.5 pp |
| 2021 | 66.7% | ₩128.69 Billion | ₩192.99 Billion | ₩64.30 Billion | ▼ -8.9 pp |
| 2020 | 75.6% | ₩117.04 Billion | ₩154.90 Billion | ₩37.86 Billion | ▲ +9.8 pp |
| 2019 | 65.7% | ₩90.54 Billion | ₩137.72 Billion | ₩47.17 Billion | ▲ +1.5 pp |
| 2018 | 64.2% | ₩86.87 Billion | ₩135.23 Billion | ₩48.35 Billion | ▼ -3.9 pp |
| 2017 | 68.2% | ₩82.83 Billion | ₩121.49 Billion | ₩38.66 Billion | ▼ -2.2 pp |
| 2016 | 70.3% | ₩78.29 Billion | ₩111.30 Billion | ₩33.01 Billion | ▼ -0.3 pp |
| 2015 | 70.7% | ₩73.73 Billion | ₩104.33 Billion | ₩30.60 Billion | ▲ +0.2 pp |
| 2014 | 70.5% | ₩71.49 Billion | ₩101.40 Billion | ₩29.91 Billion | ▼ -4.6 pp |
| 2013 | 75.1% | ₩72.28 Billion | ₩96.26 Billion | ₩23.99 Billion | ▼ -3.3 pp |
| 2012 | 78.4% | ₩69.50 Billion | ₩88.68 Billion | ₩19.18 Billion | ▲ +2.4 pp |
| 2011 | 76.0% | ₩67.23 Billion | ₩88.51 Billion | ₩21.28 Billion | — |